Albireo Pharma Current Assets

Albireo Pharma (ALBO) currently reports a current assets of $240M as of September 2022. That compares with $270M in the prior-year period — down 12.2% year over year. Use the charts on this page to explore Albireo Pharma's current assets history and peer comparisons.

Albireo Pharma's current assets decreased from $270M to $240M — a 12.2% year-over-year decrease (period ending September 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Albireo Pharma reported $240M in current assets as of September 2022. That compares with $270M in the prior-year period — down 12.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $240M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Albireo Pharma, and consider following ALBO for alerts when major investors trade the stock.

Albireo Pharma is classified in the Healthcare sector. On current assets, it currently shows $240M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ALBO with unrelated industries.